Narrowly Defined Drug Patient Assistance Programs Spark OIG Advisory

The HHS Office of Inspector General will give greater scrutiny to patient assistance programs that help enrollees in Medicare Part D plans purchase drugs if they only help patients with narrowly defined diseases or limit the range of drugs they will help cover, OIG says in updated guidance.